Cancer Research Cancer Genome no Abstract
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brady, N.
Right arrow Articles by Rassool, F. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brady, N.
Right arrow Articles by Rassool, F. V.
[Cancer Research 63, 1798-1805, April 15, 2003]
© 2003 American Association for Cancer Research


Carcinogenesis

Increased Error-prone NHEJ Activity in Myeloid Leukemias Is Associated with DNA Damage at Sites that Recruit Key Nonhomologous End-Joining Proteins1

Nicola Brady2, Terry J. Gaymes2, Manyee Cheung, Ghulam J. Mufti and Feyruz V. Rassool3

Department of Haematological Medicine, Leukaemia Sciences Laboratories, The Rayne Institute, Guy’s, King’s, St. Thomas’ School of Medicine, Denmark Hill, London SE5 9NU, United Kingdom


    ABSTRACT
 Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Double strand breaks (DSBs) are considered the most lethal form of DNA damage for eukaryotic cells, and misrepair of DSB can cause cell death, chromosome instability, and cancer. Nonhomologous end-joining (NHEJ) is a major mechanism for the repair of DSBs. We previously reported that the cancer predisposition Bloom’s syndrome and myeloid leukemias demonstrate increased NHEJ activity and consequent misrepair. In this study, we link this increased NHEJ activity and infidelity to ongoing or induced DNA damage at sites that recruit key NHEJ proteins. We show here that in myeloid leukemia cells and normal hemopoietic cells, agents that induce DSBs produce an up to 2-fold increase in this DSB misrepair activity, whereas an alkylating agent produces little or no increases. Furthermore, NHEJ overactivity after induction of DSBs is dependent on the presence of Ku70/Ku86. We also present data to explain the constitutively activated NHEJ in myeloid leukemias. Using an immunofluorescence-based assay for DNA damage, myeloid leukemias demonstrate constitutive DNA damage in the absence of treatment with DSB-inducing agents compared with normal hemopoietic cells. Importantly, damaged foci from myeloid leukemia and normal cells colocalize with NHEJ proteins Ku70 and Ku86. These data suggest that the generation of increased constitutive DNA damage may be a common pathway for the creation of NHEJ-dependent genomic instability.


    INTRODUCTION
 Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
DNA DSBs4 can arise through exogenous treatment with agents such as ionizing radiation or occur endogenously through contact with reactive oxygen species (1, 2, 3 ; reviewed in Ref. 4 ). In higher eukaryotes, these DSBs can either be repaired accurately, restoring genomic integrity, or misrepaired, resulting in cell death, genomic instability, or cancer (reviewed in Ref. 4 ). Although there are at least two mechanisms for the repair of DSBs, homologous recombination and NHEJ, the latter is regarded as the dominant mechanism for their repair in mammalian cells (reviewed in Ref. 5 ). NHEJ has been extensively characterized in rodent cells (reviewed in Ref. 6 ), identifying a pathway where the subunit proteins of the Ku70/Ku86 heterodimer bind free DNA ends at the sites of DSBs with the subsequent recruitment of DNA-PKcs to the sites of damage (7, 8, 9) . The targeted free ends are subsequently ligated by DNA ligase IV in conjunction with XRCC4 (10) . End-joining reactions can be error prone, containing deletions (<=20 bp) back to regions of microhomology of 1–6 bases (11 , 12) .

Despite the potential role of the NHEJ system in genomic instability in cancer, little is understood of the mechanism by which it participates in cancer. In fact, previous reports have been confusing in this regard because both deficiencies and increased NHEJ activity have been reported to mediate genomic instability. For example, recent studies of mouse cells null for components of the NHEJ pathway suggest the importance of these proteins for protecting against genetic instability and tumorigenesis (reviewed Ref. 13 ). Ku86-/- mice have a marked increase in chromosomal instability manifesting as breakage, translocation, and aneuploidy and a significant incidence of B-cell lymphoma (14) . On the other hand, several lines of evidence suggest that cells with an intact NHEJ pathway can give rise to chromosomal translocations and deletions in the repair of DSBs (15 , 16 ; reviewed in Refs. 4 , 17 ). Recently, Rothkamm et al. (15) showed that if multiple DSBs are generated in cells wild type for NHEJ proteins, a high frequency of misjoining and genomic rearrangements are detected. In fact, these authors showed a dramatic decrease in genomic rearrangements and misrepair in cell lines defective for NHEJ (15 , 16) . We previously demonstrated that nuclear extracts prepared from the Bloom’s chromosomal instability cells and myeloid leukemias show a significant increase in end-ligation efficiency and frequency of misrepair, as compared with normal hematopoietic cells (18 , 19) . Thus, the above, seemingly contradictory, findings associated with chromosome instability suggest that the role of NHEJ in cancer is complex and that underactivity as well as overactivity could contribute to DNA repair infidelity in neoplastic cells.

We present additional evidence for the role of increased NHEJ activity in creating genomic instability during the repair of DSBs. We show how these increases may result from cellular responses to both induced DSBs in normal cells and constitutive damage in myeloid leukemia cells, thus presenting a mechanism that may account for the increased aberrant NHEJ activity in these cells.


    MATERIALS AND METHODS
 Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Cell Culture.
Myeloid cell lines HL60 and K562 were purchased from the American Type Culture Collection. The myelomonocytic cell line, P39, was a kind gift from Richard L. Darley (University of Wales College of Medicine, Cardiff, Wales). These cell lines were cultured at 37°C (5% CO2) in Dutch-modified RPMI 1640 supplemented with 10% fetal calf serum, 4 mM glutamine and 1% penicillin/streptomycin (Sigma-Aldrich Co. Ltd., Poole, United Kingdom).

Mobilized peripheral blood and bone marrow progenitor cells (CD34+) were harvested from normal and healthy donors and were cultured as detailed previously (18 , 19) . PBLCs from normal subjects were prepared as described previously (18 , 19) . Newly diagnosed and untreated myeloid leukemia patient samples were received from hematology clinics. Clinical diagnosis and cytogenetics analysis were made on each sample before primary cell harvesting using Hypaque-Ficoll gradients. The mononuclear fraction was isolated from 10–20 ml of chronic phase CML or AML peripheral blood. Cytospins of these fractions were examined morphologically after May-Grunwald Giemsa staining and revealed the presence of >95% of CML cells or AML blasts, respectively; lymphocyte and monocyte contamination were negligible. Primary cells were cultured at 1 x 106/ml in complete medium for 24 h before nuclear extraction. Typically, between 2 x 106–107 cells were used for the preparation of nuclear extracts.

Cells were treated agents at concentrations used previously to elicit chromosome breakage (20) . Log-phase cells were irradiated on ice in a Gammacell Cobolt 60 {gamma} irradiator at doses between 3–50 (6.52 Gy/min). Cells were then returned to culture in fresh prewarmed media for a period of 30 min. Log-phase cells were cultured in 0.5 µg/ml aphidicolin (Sigma) and left in culture for 8–14 h. Thereafter, nuclear extracts were prepared. Log-phase cells treated with busulphan (5 µg/ml) were treated in a similar fashion.

Preparation of nuclear extracts and procedures for the end ligation and plasmid reactivation assays have been described previously (18 , 19) .

Plasmids and Antibodies.
pUC18 was linearized with EcoRI (MBI Fermentes, Cleveland, United Kingdom), dephosphorylated with calf intestine alkaline phosphatase (Promega, Southampton, United Kingdom), and 32P-labeled with T4 polynucleotide kinase (Promega). Goat polyclonal antisera raised against Ku86, Ku70, and DNA-PKcs and Oct-2 and their respective blocking peptides were purchased from Santa Cruz Technologies (Santa Cruz, CA). Ku86 and Ku70 blocking peptides mapped to the COOH terminus (amino acids 713–730 and 590–608) of their respective proteins. Rabbit polyclonal antisera raised against Rad51 was a kind gift from Stephen West (Imperial Cancer Research Fund, South Mimms, United Kingdom). Mouse monoclonal antibodies to BrdUrd (Becton Dickinson) were used for DNA damage assays according to manufacturer’s protocols.

It has been previously reported that cell extracts possess nuclease activity that degrades the input plasmid DNA having an antagonistic effect on end-joining efficiency (21) . The preparation of nuclear extracts alleviated this problem. We confirmed that the end-joining efficiencies observed in our assays were not the result of varying nuclease activity, by incubating nuclear extracts from different sources with linearized and labeled plasmid DNA without end ligation buffer for 24 h at 18°C. All experiments were performed in the linear phase of the end-ligation reaction, and each sample was tested for significant nuclease activity that could influence end-ligation results; no significant nuclease activity was present in our samples.

Antibody Abrogation Studies.
For antibody abrogation studies, dilutions of antisera (100 µg/ml) were incubated in the reaction mixture for 5 min at 37°C before incubation for 24 h at 18°C. Antibodies were blocked with 5-fold excess (by weight) of blocking peptide or blocking molecule (see below, anti-BrdUrd block with BrdUrd) in a small volume of PBS. The blocking reaction was incubated overnight at 4°C.

DNA Damage Studies.
These studies were performed according to the protocols of Raderschall et al. (22) . Cells were grown in BrdUrd (10 µM) for ~30 h and were shielded from light. Thereafter, the cells were washed and placed in BrdUrd-free medium for 1 h. To induce DNA damage, cells were exposed to ionizing irradiation, aphidicolin, or busulphan (see above) before washing in BrdUrd-free medium for 1 h. Cells were then washed twice in PBS and cytospun onto glass slides, and preparations were fixed in absolute methanol for 30 min at -20°C and then rinsed in ice-cold acetone for up to 1 min. Chromatin fibers were prepared from 1 x 106 cells, according to protocols of Raderschall et al. (22) . However, we modified the protocol to ensure subsequent detection of proteins binding at specific sites of interest. Proteins were cross-linked to DNA by adding formaldehyde (1% final concentration) to the culture medium for 10 min at 37°C. Aliquots of 1 x 106 cells were trypsinized and the cells cytospun onto glass slides and covered with 50 µl of 50 mM Tris HCl (pH 8), 1 mM EDTA, and 0.1% SDS. After 1-min incubation with the detergent solution, the chromatin was mechanically sheared on the slide with the aid of a glass coverslip and then fixed with methanol and acetone (as described above).

Immunofluorescence Detection.
For detection of ssDNA inside the nucleus, cytospin preparations of BrdUrd-substituted cells were processed without a prior denaturation step. Slides were incubated with blocking solution (10% BSA/4 x SSC/0.1% Tween 20) for 30 min at 37°C. Thereafter, slides were incubated with primary anti-BrdUrd (Becton Dickinson) diluted in blocking serum (1/10–1/50) and incubated for 30 min at 37°C. Slides were washed for 5 min in 4 x SSC/0.1% Tween 20 and repeated two more times. The blocking step was then repeated before slides were incubated with secondary antibody conjugated with fluorochromes diluted in blocking solution (1/200; Sigma) and subsequently washed as above. Cells were counterstained with DAPI for 1 min, rinsed in PBS, and coverslips were mounted in antifade solution ready for analysis. Control experiments were performed using anti-BrdUrd prebound to BrdUrd. In addition, cells not incorporated with BrdUrd were also used as controls. The slides were examined using Olympus fluorescent microscope with DAPI/FITC/rhodamine triple pass filters, and images were captured using a charge-coupled device camera and software (Smart Capture VP; Digital Scientific Ltd., Cambridge, United Kingdom) and data analyzed (Quips XL, Vysis, Inc., Surrey, United Kingdom).


    RESULTS
 Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
DSB-inducing Agents Influence the Efficiency of in Vitro End-Joining Activity and the Fidelity of Repair in both Normal Cells and Myeloid Leukemias.
We previously demonstrated that untreated myeloid leukemia cells manifest high frequencies of NHEJ activity and misrepair, accompanied by large plasmid deletions (50–450 bp), which are rarely observed in normal cells (19) . In this study, we sought to determine whether these alterations were linked to the pressure to repair high levels of DNA damage in these cells and, if so, whether normal cells after exposure to excessive DSBs would generate a similar pattern of NHEJ activity. Thus, using established in vitro assays, we tested the efficiency of plasmid DSB end-ligation and misrepair in nuclear extracts from IL-2-stimulated normal PBLCs (n = 4) and normal CD34+ (n = 4) after treatment with the DSB-inducing agents ionizing radiation (6 Gy) and aphidicolin (0.5 µg/ml; Refs. 18 , 19 ). The effects of treatment on end-ligation and misrepair efficiency were modest, with radiation treatment consistently demonstrating small increases, compared with aphidicolin-treated counterparts (Fig. 1 A–DCitation , Table 1Citation ). However, despite the small effects of treatment, the percentage of aberrant large plasmid deletions examined from these misrepair experiments was significantly increased in exposed normal cells, compared with untreated counterparts [33 versus 4%, mean (n = 6), P < 0.001; Fig. 1 E–GCitation ]. These data suggest that in response to excessive DSBs, normal hemopoietic cells have a similar pattern but lower level of NHEJ activity and misrepair, compared with untreated myeloid leukemia cells.



View larger version (55K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 1. Increased ligation efficiencies and misrepair frequencies in normal hemopoietic cells after induction of DSB. A, mean ligation efficiencies in normal PBLCs after treatment with {gamma} irradiation and aphidicolin no of cases studied in brackets. B and C, agarose gel of ligated pUC18 after incubation with nuclear extracts after DSB induction, (B) irradiated PBLC (6 Gy; B), aphidicolin-treated PBLC (C); first lane of gels = no nuclear extract. Ligation efficiency was calculated by two-dimensional densitometry measurement of bands converted from plasmid monomer to multimers as a percentage of total band intensities (M, monomer, D, dimer, T, trimer). D, mean misrepair frequencies in PBLCs after irradiation (6 Gy), aphidicolin (0.5 µg/ml), and busulphan (0.5 µg/ml) treatment. Cell-free extracts from treated cells were incubated with pUC18, containing a DSB within the LacZ{alpha} gene, and the purified DNA was used to transform Escherichia coli. The frequency of misrepair was calculated by counting the number of white (misrepaired) colonies as a percentage of the total (blue + white) colonies. E, mean percentage of aberrant deletions detected in PCR products from misrepaired colonies after PBLC irradiation or aphidicolin treatment. Twenty to 50 misrepaired (white) colonies were analyzed/experiment (n = 4). F and G, PCR products from PBLCs, untreated (W1–W4), irradiated (w5–10), aphidicolin-treated (W11–W17). Blue colony (b), white colony (W), L = DNA ladder (bp).

 

View this table:
[in this window]
[in a new window]

 
Table 1 Number of bacterial colonies counted in the misrepair assays

 
We next speculated whether myeloid leukemias with already high frequencies of plasmid end-ligation efficiencies and misrepair would respond further to DSB induction. After treatment with the DSB-inducing agents, ionizing radiation (6 Gy) and aphidicolin (0.5 µM), three myeloid leukemia cell lines [HL60 (promyelocytic leukemia), P39 (myelodysplastic syndrome -> myeloblastic), and K562 (CML -> erythroleukemia); Refs. 23 , 24 ] produced small but reproducible overall increases in mean end-ligation activities (Fig. 2, A–F)Citation . Primary samples [five AMLs (3 FAB M4, 1 M2, 1 M5) and three CMLs at presentation] also produced small but consistent increases in end-ligation efficiencies [AML, 51–63%; CML, 46–57%; mean (n = 3)]. The misrepair frequencies in myeloid leukemia cell lines after DSB induction showed small increases, with ionizing radiation generating up to 2-fold increases in HL60 cells (Fig. 3, A and B)Citation . Misrepair frequencies for primary samples were consistent with data for the cell lines [AML, 7–15%; CML, 5.8–11%, mean (n = 3); Table 1Citation ]. Analysis of the size of plasmid deletions by PCR clearly showed a higher frequency of aberrant deletions compared with untreated cells, corroborating the evidence for increased misrepair in these cells [90% treated versus 85% untreated, mean (n = 6); Fig. 3, C–ECitation ].



View larger version (37K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 2. Increased end-ligation efficiencies with induction of DSBs in myeloid leukemia cells. A–C, mean ligation efficiencies in myeloid leukemia cell lines after irradiation and aphidicolin treatment in HL60 (A), K562 (B), and P39 (C). pUC18 plasmid with single DSB was incubated with cell-free extracts, followed by agarose gel electrophoresis. D–F, agarose gel of ligated pUC18 after incubation with various nuclear extracts after irradiation (6 Gy), HL60 (D), K562 (E), and P39 (F). First lane of gels contains no nuclear extract. Radiation treatment shows increasing conversion to plasmid multimers (M, monomer, D, dimer, T, trimer, Te, tetramer).

 


View larger version (54K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 3. Increased misrepair frequencies in myeloid leukemia cells after induction of DSB. Mean misrepair frequencies in the myeloid leukemia cell lines, HL60 (A) and K562 (B) after treatment with {gamma} irradiation (6 Gy) or aphidicolin (0.5 µg/ml). C–E, PCR of misrepaired (white [W]) colonies derived from plasmid reactivation assays in nuclear extracts from (C) untreated HL60 cells W1–W9. D, irradiated HL60 (w1–w4), aphidicolin-treated (w5–8), and busulphan-treated (w9–w15). E, K562 untreated (w1–3), irradiated K562 (W4–8), and aphidicolin-treated (w9–12). Blue colony (B), L = DNA ladder (bp). Colony PCR was performed on blue and white (W) colonies using primers located on either side of the DSB. Blue colonies, which have an intact LacZ{alpha} gene, yield a normal PCR product of 628 bp.

 
We tested whether DNA misrepair frequencies were induced by DNA damage other than DSBs. Both normal (PBLC) and myeloid leukemia (HL60, K562, and P39) cells were treated with busulphan (5 µg/ml), an agent that alkylates DNA and is known to cause minimal DSBs. We found that there was little or no change in the misrepair frequencies, compared with untreated controls (Figs. 1DCitation and 3, A and BCitation ; Table 1Citation ). This result was additionally confirmed by PCR analysis of misrepaired colonies that showed a lower frequency of large deletions than demonstrated for radiation and aphidicolin-treated cells (Fig. 3D)Citation .

Increased End-Ligation Efficiency and Misrepair in both Myeloid Leukemias and Normal Cells in Response to DSBs Is Dependent on NHEJ Proteins.
To confirm that proteins involved in NHEJ are responsible for the increased end-ligation efficiencies and DSB misrepair observed after DSB induction, nuclear extracts from the normal (PBLC) and myeloid leukemia cells exposed to {gamma} irradiation (6 Gy) were preincubated with antibodies to Ku70 and Ku86 (diluted 1/200–1/10). Thereafter, both end-ligation efficiency and misrepair assays were performed as above. We find that there is a decrease in the end-ligation efficiency (Fig. 4A)Citation and DSB misrepair frequency (Fig. 4B)Citation with increasing concentration of Ku70 and Ku86 antibodies, with both myeloid leukemia and normal cells. Control antibodies for proteins such as Rad51 and antibodies to Ku86 and Ku70 prebound to their cognate peptides showed no decrease in misrepair frequency with increasing antibody concentration. These results show that DSB end-ligation activity and misrepair in both normal and myeloid leukemia cells after DSB induction is dependent on the presence of Ku70 and Ku86 in nuclear extracts.



View larger version (42K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 4. Decreased ligation efficiency and misrepair in radiation-treated myeloid leukemia and normal cells with increasing concentrations of antibodies against NHEJ repair proteins. A, agarose gels of ligated pUC18 after incubation with radiation-treated HL60 nuclear extracts containing antibodies to Ku86 [1/200–1/10 (Lanes 2–6) Mu, multimer.] B, frequency of misrepair with increasing concentrations of antibodies against NHEJ repair proteins. The graph shows the misrepair frequencies derived from the LacZ{alpha} reactivation assays after incubation of {gamma} irradiated (6 Gy) nuclear extracts with anti-Ku86: HL60 + anti-Ku86 and PBLC + anti-Ku86. Control experiments using blocking peptide are also indicated.

 
Eight aberrant deletions derived from experiments using irradiated normal PBLCs were sequenced to determine whether the aberrant deletions in normal cells after DNA damage are generated by alignment at regions of microhomology, a characteristic feature of NHEJ repair. We find that the deletions encompass the original EcoRI DSB and that the deleted region ranged from 26–373 bp (Table 2)Citation . Analysis of DNA sequences at the breakpoint junction demonstrated regions of microhomology in all eight clones (Table 2)Citation . This is additional evidence for the participation of NHEJ in the repair of these plasmid DSB in vitro.


View this table:
[in this window]
[in a new window]

 
Table 2 DNA sequences at breakpoint junction in misrepaired colonies from normal peripheral blood

Sequence analysis of misrepaired plasmids: end-ligation occurs through alignment of microhomologies. DNA sequencing of 10 PCR products from the LacZ{alpha} reactivation assay using irradiated PBLCs (6 Gy). The table of sequencing results shows the size of PCR product, size, and region of deletion and the short tracts of nucleotide microhomology (forward strand) at the breakpoint junction.

 
Increased Constitutive NHEJ-dependent Aberrant Misrepair in Myeloid Leukemias Is Because of Increased Levels of Constitutive DNA Damage.
The work above indicates that induced DSB increases NHEJ-mediated ligation efficiency and misrepair of test plasmids in in vitro assays in both normal and leukemia cells. These results and our previous studies (18 , 19) raise the important question of whether any such increased basal ligation efficiencies and misrepair in leukemia cells might represent a response to constitutive endogenous DNA damage and repair activities in such cells.

We directly tested the levels of DNA damage in normal and myeloid leukemia cells using an assay that has previously been used to detect DNA damage after treatment with DSB-inducing agents, and the Rad 51 DSB repair protein has previously been localized to these sites (22) . This assay relies on the specificity of anti-BrdUrd for ssDNA after treatment of BrdUrd-incorporated cells with DNA damaging agents. It is thought that after formation of a DSB, this assay detects the ssDNA created to expose DNA to repair proteins and thus can be considered a marker for this DNA damage. Thus, ssDNA regions at the sites of DSB can be visualized and quantified as very bright BrdUrd-positive nuclear foci. We, thus assessed DNA damage in normal myeloid leukemic and normal cells after treatment with radiation, aphidicolin, and etoposide. To confirm previous data, we exposed normal hematopoietic cells [IL-2-stimulated T lymphocytes (n = 4), CD34+ cells (n = 3)] to the DSB-inducing agents (ionizing radiation, aphidicolin, and etoposide). Treatment with these agents results in a significant increase in cells containing DNA damage foci [7–26%, mean (n = 3), P < 0.001; Table 2Citation ]. In contrast, control experiments where anti-BrdUrd was preincubated with BrdUrd showed no damage foci (Fig. 5)Citation . Strikingly, even in the absence of treatment with DNA damaging agents, myeloid leukemia cell lines (HL60 and K562) and primary cells [CML (n = 2)] show low but significant levels of constitutive DNA damage compared with normal hemopoietic cells [IL-2-stimulated T lymphocytes (n = 4), CD34+ cells (n = 3); 34 versus 7%, mean (n = 3), P < 0.001; Table 3Citation , Fig. 5Citation ]. In contrast, myeloid leukemia cells treated with busulphan demonstrated a pattern of DNA damage foci similar to untreated cells (Table 2Citation , Fig. 5Citation ). Normal cells treated with busulphan also appear to have less DNA damage compared with counterparts treated with DSB-inducing agents (Table 3Citation , Fig. 5Citation ).



View larger version (55K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 5. DNA damage foci in normal and myeloid leukemia cells pre and post treatment. Normal myeloid progenitor (CD34+) and myeloid leukemia (K562 and HL60) cells grown in BrdUrd for 30 h and treated with ionizing radiation, aphidicolin, etoposide, and busulphan. Cells were indirectly stained for ssDNA regions using anti-BrdUrd antibodies in conjunction with mouse IgG conjugated with FITC (foci stained green) and counterstained with DAPI (nuclei stained blue). Untreated myeloid leukemia cells show low levels of ssDNA damage, compared with normal cells. Treated cells show increased levels of DNA damage. Control cells were detected with anti-BrdUrd, prebound to its cognate peptide, and show no damage foci.

 

View this table:
[in this window]
[in a new window]

 
Table 3 DNA damage foci in myeloid leukemia and normal cells after DNA damage

 
Importantly, the constitutive damage in myeloid leukemias could also be demonstrated by examining chromatin fibers from these cells, additionally confirming the above results (Fig. 6A)Citation . Chromatin fibers were prepared from BrdUrd-incorporated normal (PBLC) and myeloid leukemic cells (HL60 and K562) before and after treatment with ionizing radiation (6 Gy). Between 15 and 20 fibers were examined for BrdUrd-positive regions of DNA damage in each cell preparation. These experiments were performed three times. Although fibers from untreated normal cells showed no BrdUrd-positive regions, untreated myeloid leukemia cells demonstrated fibers containing DNA damage (K562, 20%; HL60, 26%). After ionizing radiation, chromatin fibers from normal cells demonstrate DNA damage (12%), and fibers from myeloid leukemias, in general, appear to contain more damage, compared with untreated counterparts. However, the variability in the stretch of fibers precluded definitive quantitation of the perceived increased damage in treated myeloid leukemia cells (Fig. 6A)Citation .



View larger version (29K):
[in this window]
[in a new window]
[Download PPT slide]
 
Fig. 6. DNA damage foci from untreated myeloid leukemias and treated normal cells colocalize with Ku86. A, BrdUrd detection of constitutive DNA damage on chromatin fibers from untreated and etoposide-treated HL60 cells. DNA damaged regions are detected indirectly with mouse anti-BrdUrd in conjunction with FITC-conjugated mouse IgG (green stain) and counterstained with DAPI (chromatin fiber stained blue). B, colocalization of DNA damaged regions on chromatin fibers with Ku86. Consecutive images of DNA damage regions on chromatin fibers detected indirectly with anti-BrdUrd (green signal), followed by Ku86 with anti-Ku86 antibodies (red signal) and a merged image of the two previous images, showing colocalization of some of the regions of DNA damage with Ku86 (yellow signal).

 
To determine whether the basal and induced damage foci are indeed associated with DSBs, we performed immunofluorescence studies to colocalize DNA damage with NHEJ proteins. To ensure that we could accurately detect and colocalize endogenous proteins bound to discrete sites of DNA damage, we cross-linked proteins bound to DNA before preparation of chromatin fibers (see "Materials and Methods"). Thus, chromatin fibers from untreated myeloid leukemia cells (HL60 and K562) and irradiated PBLCs (n = 3) were examined for the presence of both DNA damage and the key NHEJ proteins, Ku86 and Ku70. Between 10 and 15 chromatin fibers containing regions of BrdUrd-positive DNA damage were examined in each of three experiments. Our results demonstrated that the majority of DNA damage regions colocalized with Ku86 or Ku70 in myeloid leukemias [HL60, 80% mean (n = 3)] or PBLCs after ionizing radiation [72% mean (n = 3); Fig. 6BCitation ]. These data provide evidence that both the constitutively expressed damage in myeloid leukemia cells and induced damage in normal cells are DSBs, colocalizing with proteins intrinsic to the NHEJ pathway.


    DISCUSSION
 Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In this study, we demonstrate that NHEJ activity and misrepair responds specifically to DNA damage in the form of DSBs in both normal hemopoietic and myeloid leukemia cells. Importantly, we link our previous observations of increased NHEJ activity and misrepair in myeloid leukemias to DNA damage in these cells. We have taken our observations from an in vitro plasmid-based assay to a whole cell context to visualize the sites of the DNA damage colocalized with key NHEJ proteins in situ.

A striking finding of this study is that normal cells exposed to agents that induce DSBs demonstrate a similar pattern of NHEJ activity and misrepair to frank leukemia cells, albeit at much lower levels. {gamma} Irradiation and, to a lesser extent, aphidicolin treatment generate increased frequencies of aberrant NHEJ, most likely in accordance with their ability to induce DSBs (25) . In contrast, alkylating agents, which generate a minimal amount of DSBs, demonstrate little or no effect on NHEJ activity and misrepair (25) . These findings suggests that excessive DNA damage may force normal NHEJ components to process DSB aberrantly, resulting in possible chromosomal instability.

An important ramification of our findings relates to causative effects of human leukemia and how the disease may progress. Our data suggest that genomic instability may actually start in normal cells challenged to respond to damage by DSB-inducing agents. Several lines of evidence suggest that a major consequence to health of exposure to ionizing radiation is genomic instability and leukemia (26) . For example, leukemias that arose in atomic bomb survivors and radiation therapy-related leukemias exhibit high levels of chromosome abnormalities (27 , 28) . This data is in keeping with the idea that the type of genomic instability generated in radiation-induced leukemias is associated with the repair of DSBs, of which NHEJ is a major participant. Therefore, the increased NHEJ activity and consequent misrepair we have observed is an attractive candidate for the generation of chromosomal instability in myeloid leukemias in vivo.

A key aspect of our present work is to use a whole cellular context to tie constituents of the NHEJ repair complex to the increased damage misrepair in leukemia cells. In addition to titration studies with antibodies to key NHEJ repair proteins that strongly indicate in our in vitro assays that infidelity of accompanying DSB repair is dependent on the presence of Ku70 and Ku86, we directly visualize these proteins at ongoing sites of damage in leukemia cells and at such sites arising in response to DSB-inducing agents. Although the basis for the repair infidelity of the Ku70/86 heterodimer is unclear, our data suggest that the normal NHEJ apparatus is capable of DSB misrepair when challenged with excessive DSBs. Our direct sequencing analyses of plasmid deletions generated in normal cells after DSB induction suggests that the repair occurred through ligation of distant regions of microhomology, a characteristic of the NHEJ mechanism. Furthermore, our data are in keeping with recent studies in normal eukaryotic cells that demonstrate NHEJ can generate genomic rearrangements when DSBs are induced (15 , 16) .

Much remains to be learned about the mechanisms through which increased misrepair NHEJ activity arises in myeloid leukemias. Examination of proteins specifically involved in this poorly understood misrepair pathway will additionally elucidate its role and activation in response to DNA damage. Furthermore, the structure and phosphorylation of Ku and Ku binding proteins will provide additional insights into misrepair activity in myeloid leukemias. However, the high frequency of chromosome abnormalities in cancer cells is likely to result, in part, from a high rate of error-prone NHEJ at regions of DSBs, which may be generated in response to increased levels of endogenous DNA damage in these cells. Our data indicate that this is a process that could be fundamental to the risk of developing diseases like leukemia and to all stages of progression of such malignancies once they become established.


    ACKNOWLEDGMENTS
 
We thank Professor Stephen Baylin for helpful suggestions while writing the manuscript.


    FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by the Elimination of Leukaemia Fund (to F. V. R., T. J. G., N. B., M. C.). Back

2 These authors contributed equally to the work. Back

3 To whom requests for reprints should be addressed, at Department of Haematological Medicine, Leukaemia Sciences Laboratories, The Rayne Institute, GKT, Denmark Hill, London SE5 9NU, United Kingdom. Phone: 44-207-848-5821; Fax: 44-207-848-5814; E-mail: feyruz.rassool{at}kcl.ac.uk Back

4 The abbreviations used are: DSB, double strand break; DNA-PKcs, DNA-protein kinase; PBLC, peripheral blood lymphocyte; CML, chronic myelogenous leukemia; AML, acute myelogenous leukemia; BrdUrd, bromodeoxyuridine; ssDNA, single-stranded DNA; DAPI, 4',6-diamidino-2-phenylindole; IL, interleukin. Back

Received 10/10/02. Accepted 2/19/03.


    REFERENCES
 Top
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Olive P. L. The role of single and double strand breaks in cell killing by ionizing radiation. Radiat. Res., 150: S42-S51, 2000.
  2. Morgan W. F., Corcoran J., Hartmann A., Kaplan M. I., Limoli C. L., Ponnaiya B. Double strand breaks, chromosomal rearrangements, and genomic instability. Mutat. Res., 404: 125-128, 1998.[Medline]
  3. Jeggo P. A. DNA double strand breakage and repair. Adv. Genet., 38: 185-218, 1998.[Medline]
  4. Elliott B., Jasin M. Double-strand breaks and translocations in cancer. Cell. Mol. Lif. Sci., 59: 373-385, 2002.[Medline]
  5. Khanna K. K., Jackson S. P. DNA double strand breaks: signalling, repair and the cancer connection. Nat. Genet., 27: 247-254, 2001.[Medline]
  6. Zdzienicka M. Z. Mammalian mutants defective in the response to ionizing radiation-induced DNA damage. Mutat. Res., 336: 203-213, 1995.[Medline]
  7. Mimori T., Hardin J. A. Mechanism of action between ku protein and DNA. J. Biol. Chem., 261: 10375-10379, 1986.[Abstract/Free Full Text]
  8. Falzon M., Fewell J. W., Kuff E. L. EBP-80, a transcription factor closely resembling the human autoantigen ku, recognizes single- to double-strand transitions in DNA. J. Biol. Chem., 268: 10546-10552, 1993.[Abstract/Free Full Text]
  9. Gottlieb T., Jackson S. The DNA-dependent protein kinase: requirement for DNA ends and association with ku antigen. Cell, 72: 131-142, 1993.[Medline]
  10. Grawunder U., Wilm M., Wu X. T., Kulesza P., Wilson T. E., Mann M., Lieber M. R. Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature (Lond.), 388: 492-495, 1997.[Medline]
  11. Roth D. B., Porter T. N., Wilson J. H. Mechanism of nonhomologous recombination in mammalian cells. Mol. Cell. Biol., 5: 2599-2607, 1985.[Abstract/Free Full Text]
  12. Roth D. B., Wilson J. H. Nonhomologous recombination in mammalian cells: role for the short sequence homologies in the joining reaction. Mol. Cell. Biol., 6: 4295-4304, 1986.[Abstract/Free Full Text]
  13. Pierce A. J., Jasin M. NHEJ deficiency and disease. Mol. Cell., 6: 1160-1161, 2001.
  14. Difilipiantonio M. J., Zhu J., Chen H. T., Meffre E., Nussenzweig M. C., Max E. E., Ried T., Nussenzweig A. DNA repair protein ku80 suppresses chromosomal aberrations and malignant transformation. Nature (Lond.), 400: 510-513, 2000.
  15. Rothkamm K., Kuhne M., Jeggo P. A., Lobrich M. Radiation-induced genomic rearrangements formed by nonhomologous end-joining of DNA double-strand breaks. Cancer Res., 61: 3886-3893, 2001.[Abstract/Free Full Text]
  16. Rief N., Lobrich M. Efficient rejoining of radiation-induced DNA double-strand breaks in centromeric DNA of human cells. J. Biol. Chem., 277: 20572-20582, 2002.[Abstract/Free Full Text]
  17. Elliott B., Jasin M. Double-strand breaks and translocations in cancer. Cell. Mol. Lif. Sci., 59: 373-385, 2002.
  18. Gaymes T. J., North P. S., Brady N., Hickson I. D., Mufti G. J., Rassool F. V. Increased error-prone nonhomologous DNA end-joining: a proposed mechanism of chromosomal instability in Bloom’s syndrome. Oncogene, 21: 2525-2533, 2002.[Medline]
  19. Gaymes T. J., Mufti G. J., Rassool F. V. Myeloid leukemias have increased activity of the nonhomologous end-joining pathway and concomitant DNA misrepair that is dependant on the Ku70/86 heterodimer. Cancer Res., 62: 2791-2797, 2002.[Abstract/Free Full Text]
  20. Yunis J. J., Lee Soreng L., Bowe A. E. Fragile sites are targets of diverse mutagens and carcinogens. Oncogene, 1: 59-69, 1987.[Medline]
  21. Baumann P., West S. C. DNA end-joining catalyzed by human cell-free extracts. Proc. Natl. Acad. Sci. USA, 95: 14066-14070, 1998.[Abstract/Free Full Text]
  22. Raderschall E., Golub E. I., Haaf T. Nuclear foci of mammalian recombination proteins are located at DNA regions after DNA damage. Proc. Natl. Acad. Sci. USA, 96: 1921-1926, 1999.[Abstract/Free Full Text]
  23. Nagai M., Seki S., Kitahara T., Abe T., Minato K., Watanabe S., Shimoyama M. A novel human myelomonocytoid cell line, P39/Tsugane, derived from overt leukemia following myelodysplastic syndrome. Gann, 75: 1100-1107, 1984.[Medline]
  24. Koeffler H. P., Golde D. W. Human myeloid leukemia cell lines. Blood, 56: 344-350, 1980.[Abstract/Free Full Text]
  25. Friedberg E. Walker G. Siede W. eds. . DNA repair and mutagenesis, ASM Press Washington DC 1995.
  26. Preston D. L., Kusumi S., Tomanaga M., Izumi S., Ron E., Kuramoto A., Kamada N., Dohy H., Mtasui T., Nonaka H., Thompson D. E., Soda M., Mabuchi K. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma, multiple myeloma, 1950–1987. Radiat. Res., 137: S68-S97, 1994.[Medline]
  27. Nakanishi M., Tanaka K., Shintani T., Takahashi T., Kamada N. Chromosomal instability in acute myelocytic leukemia and myelodysplastic syndrome patients among atomic bomb survivors. J. Rad. Res., 40: 159-167, 1999.
  28. Philip P., Pedersen-Bjergaard J. Cytogenetic, clinical, and cytologic characteristics of radiotherapy-related leukemias. Cancer Genet. Cytogenet., 31: 227-236, 1988.[Medline]



This article has been cited by other articles:


Home page
haematolHome page
T. J. Gaymes, S. Shall, F. Farzaneh, and G. J. Mufti
Chromosomal instability syndromes are sensitive to poly ADP-ribose polymerase inhibitors
Haematologica, December 1, 2008; 93(12): 1886 - 1889.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Sallmyr, A. E. Tomkinson, and F. V. Rassool
Up-regulation of WRN and DNA ligase III{alpha} in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks
Blood, August 15, 2008; 112(4): 1413 - 1423.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Sallmyr, J. Fan, K. Datta, K.-T. Kim, D. Grosu, P. Shapiro, D. Small, and F. Rassool
Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML
Blood, March 15, 2008; 111(6): 3173 - 3182.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. V. Rassool, T. J. Gaymes, N. Omidvar, N. Brady, S. Beurlet, M. Pla, M. Reboul, N. Lea, C. Chomienne, N. S.B. Thomas, et al.
Reactive Oxygen Species, DNA Damage, and Error-Prone Repair: A Model for Genomic Instability with Progression in Myeloid Leukemia?
Cancer Res., September 15, 2007; 67(18): 8762 - 8771.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Rink, A. Slupianek, T. Stoklosa, M. Nieborowska-Skorska, K. Urbanska, I. Seferynska, K. Reiss, and T. Skorski
Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells
Blood, July 15, 2007; 110(2): 651 - 660.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
T. J. Gaymes, R. A. Padua, M. Pla, S. Orr, N. Omidvar, C. Chomienne, G. J. Mufti, and F. V. Rassool
Histone Deacetylase Inhibitors (HDI) Cause DNA Damage in Leukemia Cells: A Mechanism for Leukemia-Specific HDI-Dependent Apoptosis?
Mol. Cancer Res., August 1, 2006; 4(8): 563 - 573.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Deriano, O. Guipaud, H. Merle-Beral, J.-L. Binet, M. Ricoul, G. Potocki-Veronese, V. Favaudon, Z. Maciorowski, C. Muller, B. Salles, et al.
Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway
Blood, June 15, 2005; 105(12): 4776 - 4783.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. V. Rassool
Genetic rearrangements beget genomic instability
Blood, December 1, 2004; 104(12): 3424 - 3425.
[Full Text] [PDF]


Home page
BloodHome page
M. O. Nowicki, R. Falinski, M. Koptyra, A. Slupianek, T. Stoklosa, E. Gloc, M. Nieborowska-Skorska, J. Blasiak, and T. Skorski
BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand breaks
Blood, December 1, 2004; 104(12): 3746 - 3753.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-G. Wang, C. Nnakwe, W. S. Lane, M. Modesti, and K. M. Frank
Phosphorylation and Regulation of DNA Ligase IV Stability by DNA-dependent Protein Kinase
J. Biol. Chem., September 3, 2004; 279(36): 37282 - 37290.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brady, N.
Right arrow Articles by Rassool, F. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brady, N.
Right arrow Articles by Rassool, F. V.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online